Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVACINCAPTAD PEGOL vs AVAPRITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVACINCAPTAD PEGOL vs AVAPRITINIB: Safety Overview

Metric AVACINCAPTAD PEGOL AVAPRITINIB
Total FAERS Reports 202 10,117
Deaths Reported 3 302
Death Rate 1.5% 3.0%
Hospitalizations 2 942
Average Patient Age 82.3 yrs 62.4 yrs
% Female Patients 61.9% 56.5%
FDA Approval Date Aug 4, 2023 Jan 9, 2020
Manufacturer Astellas Pharma US, Inc. Blueprint Medicines Corporation
Route INTRAVITREAL ORAL
Marketing Status Prescription Prescription